These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 6682755)

  • 1. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
    Winneker RC; Clark JH
    Endocrinology; 1983 Jun; 112(6):1910-5. PubMed ID: 6682755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
    Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus.
    Lyman SD; Jordan VC
    Biochem Pharmacol; 1985 Aug; 34(15):2795-806. PubMed ID: 4015716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
    Sheen YY; Simpson DM; Katzenellenbogen BS
    Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogen binding sites in brain and pituitary of ovariectomized rats.
    Gray JM; Ziemian L
    Brain Res; 1992 Apr; 578(1-2):55-60. PubMed ID: 1511289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Jordan VC; Gosden B
    Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
    Faye JC; Fargin A; Bayard F
    Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ; Jordan VC
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
    Boctor AM; Band P; Grossman A
    Endocrinology; 1983 Aug; 113(2):453-62. PubMed ID: 6872936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
    Watts CK; Sutherland RL
    Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
    Gulino A; Pasqualini JR
    Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of tamoxifen in the chicken.
    Lazier CB
    J Steroid Biochem; 1987; 27(4-6):877-82. PubMed ID: 3320566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol and tamoxifen interaction at receptor sites at 37 C.
    Fishman JH
    Endocrinology; 1983 Sep; 113(3):1164-6. PubMed ID: 6191968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen decreases the estradiol induced progesterone receptors by interfering with nuclear estrogen receptor accumulation.
    Castellano-Díaz E; González-Quijano MI; Limiñana JM; Díaz-Chico BN
    J Steroid Biochem; 1989 Jul; 33(1):133-9. PubMed ID: 2761261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of tamoxifen-specific binding sites and estrogen receptors by estradiol and progesterone in the neonatal uterus of guinea pig.
    Gulino A; Pasqualini JR
    Endocrinology; 1983 May; 112(5):1871-3. PubMed ID: 6832074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and inducibility of the Uterine estrogen-induced protein, IP, during the rat estrous cycle: clues to uterine estrogen sensitivity.
    Katzenellenbogen BS
    Endocrinology; 1975 Feb; 96(2):289-97. PubMed ID: 163181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.